Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXW9TR
|
||||
Drug Name |
N-{(S)-3-Cyclohexyl-1-[2-(4-methoxy-phenylamino)-ethylcarbamoyl]-propyl}-3-methyl-benzamide
|
||||
Synonyms |
CHEMBL198147
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C27H37N3O3
|
||||
Canonical SMILES |
COc1ccc(NCCNC(=O)[C@H](CCC2CCCCC2)NC(=O)c3cccc(C)c3)cc1
|
||||
InChI |
InChI=1S/C27H37N3O3/c1-20-7-6-10-22(19-20)26(31)30-25(16-11-21-8-4-3-5-9-21)27(32)29-18-17-28-23-12-14-24(33-2)15-13-23/h6-7,10,12-15,19,21,25,28H,3-5,8-9,11,16-18H2,1-2H3,(H,29,32)(H,30,31)/t25-/m0/s1
|
||||
InChIKey |
MNECACXIBPFIKN-VWLOTQADSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | [1587926] | ||
Cathepsin L | Target Info | [1587926] | |||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
Trafficking and processing of endosomal TLR | |||||
MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.